69214-19-3 Usage
Uses
Used in Scientific Research:
2-Amino-6-chloro-3-phenylpyridine is used as a research chemical for [application reason] in the field of biochemical and scientific studies. Its unique structure and properties make it a valuable compound for exploring various chemical reactions and interactions.
Used in Pharmaceutical Development:
In the pharmaceutical industry, 2-Amino-6-chloro-3-phenylpyridine is used as a key intermediate in the synthesis of various drug molecules. Its presence in the molecular structure can contribute to the development of new therapeutic agents with potential applications in treating different diseases.
Used in Chemical Synthesis:
2-Amino-6-chloro-3-phenylpyridine is used as a building block in the synthesis of more complex organic compounds. Its reactivity and structural features make it a useful component in the creation of novel chemical entities with potential applications in various industries, such as materials science and specialty chemicals.
Check Digit Verification of cas no
The CAS Registry Mumber 69214-19-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,9,2,1 and 4 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 69214-19:
(7*6)+(6*9)+(5*2)+(4*1)+(3*4)+(2*1)+(1*9)=133
133 % 10 = 3
So 69214-19-3 is a valid CAS Registry Number.
InChI:InChI=1/C11H9ClN2/c12-10-7-6-9(11(13)14-10)8-4-2-1-3-5-8/h1-7H,(H2,13,14)
69214-19-3Relevant academic research and scientific papers
TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF
-
Page/Page column 60; 61, (2016/10/31)
The present invention is directed to bicyclic heteroaryl benzamide compounds of formulas (I) which are tropomyosin-related kinase (Trk) family protein kinase inhibitors, and hence are useful in the treatment of pain, inflammation, cancer, restenosis, atherosclerosis, psoriasis, thrombosis, a disease, disorder, injury, or malfunction relating to dysmyelination or demyelination or a disease or disorder associated with abnormal activities of nerve growth factor (NGF) receptor TrkA.
TRKA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF
-
Page/Page column 60; 61, (2015/12/30)
The present invention is directed to six membered heteroaryl benzamide compounds of formula (I), which are tropomyosin-related kinase (Trk) family protein kinase inhibitors, and hence are useful in the treatment of pain, inflammation, cancer, restenosis, atherosclerosis, psoriasis, thrombosis, a disease, disorder, injury, or malfunction relating to dysmyelination or demyelination or a disease or disorder associated with abnormal activities of nerve growth factor (NGF) receptor TrkA.
